Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102011 · ClinicalTrials.gov registry record · Phase 3
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,952
- Enrollment target
NCT00102011: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00102011 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 4,952 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (541% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102011, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,952 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests, such as colonoscopy and fecal occult blood test, may help doctors find tumor cells early and plan better treatment for colorectal cancer. PURPOSE: This randomized phase III trial is studying colonoscopy to see how well it works compared to fecal occult blood test in screening healthy participants for colorectal cancer.
Interventions
- PROCEDURE standard follow-up care
- PROCEDURE fecal occult blood test
- PROCEDURE screening colonoscopy
- PROCEDURE annual screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,952 participants |
| Start Date | 2000-05-25 |
| Est. Completion | 2026-03-05 |
| Phase | Phase 3 |
What the finished NCT00102011 record still lists
NCT00102011 is an interventional study that assigns participants to a tested intervention. Its 4,952 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (541% higher).
The record links to 0 conditions, and to 4 interventions - of which standard follow-up care is the first listed.
NCT00102011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00102011 about?
NCT00102011 is a clinical study titled "Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer". RATIONALE: Screening tests, such as colonoscopy and fecal occult blood test, may help doctors find tumor cells early and plan better treatment for colorectal cancer. PURPOSE: This randomized phase III trial is studying colonoscopy to see how well it works compared to fecal occult blood test in scre...
What is the current status of trial NCT00102011?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,952 participants. The study started on 2000-05-25. Estimated completion is 2026-03-05.
What interventions are being tested in trial NCT00102011?
The interventions under investigation include: standard follow-up care (PROCEDURE), fecal occult blood test (PROCEDURE), screening colonoscopy (PROCEDURE), annual screening (PROCEDURE).
Who is sponsoring clinical trial NCT00102011?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00102011's enrollment target sits among peer trials
4,952 52nd of 2000 higher than 1,949 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI